Quantcast
U.S. CDC panel to discuss Pfizer COVID-19 booster shot for 12- to 15-year olds – Metro US

U.S. CDC panel to discuss Pfizer COVID-19 booster shot for 12- to 15-year olds

FILE PHOTO: Pfizer/BioNTech COVID-19 vaccine shows 90.7% efficacy in trial
FILE PHOTO: Pfizer/BioNTech COVID-19 vaccine shows 90.7% efficacy in trial in children

(Reuters) – A U.S. Centers for Disease Control and Prevention advisory panel is set to meet on Wednesday to discuss the use of a booster dose of Pfizer and BioNTech’s COVID-19 vaccine for children aged 12 to 15 years, according to the agency’s website https://www.cdc.gov/vaccines/acip/index.html.

(Reporting by Manojna Maddipatla in Bengaluru; Editing by Ramakrishnan M.)

More from our Sister Sites